240 related articles for article (PubMed ID: 14982635)
21. Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?
Platteeuw JJ
Trop Med Int Health; 2006 Jun; 11(6):804-8. PubMed ID: 16772001
[TBL] [Abstract][Full Text] [Related]
22. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum.
Wang P; Nirmalan N; Wang Q; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 May; 135(1):77-87. PubMed ID: 15287589
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
[TBL] [Abstract][Full Text] [Related]
24. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
25. Folate metabolism in malaria.
Ferone R
Bull World Health Organ; 1977; 55(2-3):291-8. PubMed ID: 338184
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
27. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
[TBL] [Abstract][Full Text] [Related]
28. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
[TBL] [Abstract][Full Text] [Related]
29. Exploring the folate pathway in Plasmodium falciparum.
Hyde JE
Acta Trop; 2005 Jun; 94(3):191-206. PubMed ID: 15845349
[TBL] [Abstract][Full Text] [Related]
30. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
[TBL] [Abstract][Full Text] [Related]
31. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
32. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
35. Biochemical aspects of drug action and resistance in malaria parasites.
Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
[TBL] [Abstract][Full Text] [Related]
36. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
37. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
38. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
Malamba SS; Mermin J; Reingold A; Lule JR; Downing R; Ransom R; Kigozi A; Hunt BM; Hubbard A; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
[TBL] [Abstract][Full Text] [Related]
40. Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from
Yogavel M; Nettleship JE; Sharma A; Harlos K; Jamwal A; Chaturvedi R; Sharma M; Jain V; Chhibber-Goel J; Sharma A
J Biol Chem; 2018 Sep; 293(39):14962-14972. PubMed ID: 30104413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
